Amneal Pharmaceuticals News

Amneal Pharmaceuticals | 8-K: Current report

Aug 9 06:18 ET

Amneal Pharmaceuticals | 8-K: Current report

May 7 16:37 ET

Amneal Pharmaceuticals | 8-K: AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 3 06:15 ET

Amneal Pharmaceuticals | DEFA14A: Others

Mar 22 08:07 ET

Amneal Pharmaceuticals | DEF 14A: Definitive information statements

Mar 22 08:06 ET

Amneal Pharmaceuticals | 8-K: AMNEAL REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Mar 1 06:14 ET

Amneal Pharmaceuticals | 8-K: Current report

Jan 10 00:00 ET

Amneal Pharmaceuticals | 8-K: Current report

Dec 15, 2023 16:15 ET

Amneal Pharmaceuticals | 8-K/A: Current report (Amendment)

Dec 15, 2023 16:06 ET

Amneal Pharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Nov 20, 2023 06:07 ET

Amneal Pharmaceuticals | 8-K: Current report

Nov 14, 2023 17:04 ET

Amneal Pharmaceuticals | S-8 POS: S-8 POS

Nov 8, 2023 17:15 ET

Amneal Pharmaceuticals | S-8 POS: S-8 POS

Nov 8, 2023 17:14 ET

Amneal Pharmaceuticals | S-8 POS: S-8 POS

Nov 8, 2023 17:13 ET

Amneal Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Nov 8, 2023 17:13 ET

Amneal Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Nov 8, 2023 17:12 ET

Amneal Pharmaceuticals | 8-K: AMNEAL REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Nov 7, 2023 06:21 ET

Amneal Pharmaceuticals | 8-K: AMNEAL REPORTS CERTAIN PRELIMINARY THIRD QUARTER 2023 FINANCIAL RESULTS AND RAISES FULL YEAR 2023 FINANCIAL GUIDANCE

Oct 23, 2023 16:16 ET

Amneal Pharmaceuticals | 8-K: Current report

Oct 17, 2023 06:51 ET

Amneal Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 9, 2023 08:32 ET